Radcliffe Capital Management’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Radcliffe Capital Management’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53,288	Closed	-$1.57K	–	549
2023 Q2	$1.57K	Hold	53,288	–	–	﹤0.01%	563
2023 Q1	$3.29K	Sell	53,288 -400	-0.7%	-$34	﹤0.01%	652
2022 Q4	$36.6K	Hold	53,688	–	–	﹤0.01%	873
2022 Q3	$145K	Hold	53,688	–	–	﹤0.01%	1157
2022 Q2	$545K	Hold	53,688	–	–	0.01%	1102
2022 Q1	$541K	Hold	53,688	–	–	0.01%	1107
2021 Q4	$537K	Hold	53,688	–	–	0.01%	963
2021 Q3	$534K	Hold	53,688	–	–	0.02%	820
2021 Q2	$533K	Hold	53,688	–	–	0.02%	842
2021 Q1	$528K	Buy	+53,688	New	+$109K	0.02%	636

Other funds holding APGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Radcliffe Capital Management's APGNW Position: Q3 2023 in Review

Radcliffe Capital Management sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 53,288 shares — an estimated $1.57K sold.

Radcliffe Capital Management first reported a position in APGNW in Q1 2021 and held it in 10 quarters. The position peaked at $545K in Q2 2022. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

Radcliffe Capital Management reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Radcliffe Capital Management sold 53,288 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $1.57K.
Radcliffe Capital Management first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and held it in 10 quarters.
Radcliffe Capital Management's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $545K in Q2 2022.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.